Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1213-1221

  Lee, Jong Hoon ^a   Jang, Hong Seok ^a   Kim, Jun Gi ^a   Cho, Hyun Min ^b   Shim, Byoung Yong ^b   Oh, Seong Taek ^a   Yoon, Sei Chul ^a   Kim, Yeon Sil ^a   Choi, Byung Ock ^a   Kim, Sung Hwan ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINATE CALCIUM;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERINEURAL INVASION; PREOPERATIVE TREATMENT; PRIMARY TUMOR; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOTHERAPY; RECTUM CANCER; RECTUM RESECTION; TOTAL MESORECTAL EXCISION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84862505590     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2062-z     Document Type: Article

References (30)

1. Kim DW, Jeong SY, Kim DY. Treatment patterns for colorectal cancer patients at the national cancer center Korea in 2003. J Korean Soc Coloproctol. 2007;23:245-9.
2. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351:1731-40.
3. Gerard J, Conroy T, Bonnetain F, Bouché O, Chapet O, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620-5. (Pubitemid 46630960)
4. Lee JH, Kim SH, Kim JG, Cho HM, Shim BY. Preoperative Chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys. 2011;82:431-8.
5. Wolthuis AM, Penninckx F, Haustermans K, Ectors N, Van Cutsem E, et al. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation. Ann Surg Oncol. 2011;18:684-90.
6. de Campos-Lobato LF, Stocchi L, da Luz MA, Geisler D, Dietz DW, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol. 2011;18:1590-8.
7. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15:729-37.
8. Croog VJ, Abu-Rustum NR, Barakat RR, Alektiar KM. Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion. Gynecol Oncol. 2008;111:49-54.
9. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005;23:6533-9. (Pubitemid 46190245)
10. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Inclusion of vasculature-related variables in the Dukes staging system of colon cancer. Clin Cancer Res. 2005;11:8653-60. (Pubitemid 43005913)
11. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: colon cancer, Washington. 2011: COL-3.
12. Heide J, Krull A, Berger J. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys. 2004;58:773-8. (Pubitemid 38221134)
13. Law WL, Chu KW. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors. World J Surg. 2002;26:1272-6. (Pubitemid 36920255)
14. Ptok H, Meyer F, Steinert R, Vieth M, Ridwelski K, et al. No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer-results of a multicenter observational study. Int J Colorectal Dis. 2007;22:749-56. (Pubitemid 46863752)
15. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum: II. The influence of blood vessel invasion. Cancer. 1988;61:1417-24. (Pubitemid 18076417)
16. Yoon SM, Kim DY, Kim TH, Jung KH, Chang HJ, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2007;69:1167-72. (Pubitemid 47625840)
17. Tuchiya A, Ando Y, Kikuchi Y, Kanazawa M, Sato H, et al. Venous invasion as a prognostic factor in colorectal cancer. Surg Today. 1995;25:950-3.
18. Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Cancer. 1996;78:403-8. (Pubitemid 26250523)
19. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol. 2001;195:171-8. (Pubitemid 32899025)
20. American Joint Committee on Cancer (AJCC). Cancer staging manual, 7th edn. New York: Springer-Verlag; 2009. p. 143-64.
21. Hoda SA, Hoda RS, Merlin S, Shamonki J, Rivera M. Issues relating to lymphovascular invasion in breast carcinoma. Adv Anat Pathol. 2006;13:308-15. (Pubitemid 44673446)
22. Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, et al. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 2006;38:438-44. (Pubitemid 44605889)
23. Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol. 2009;35:1071-7.
24. Rodel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688-96. (Pubitemid 46211512)
25. Szynglarewicz B, Matkowski R, Halon A, Lacko A, Stepien M, et al. Association between histological type of tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with sphincter-preserving total mesorectal excision. Pathol Oncol Res. 2010;16:201-6.
26. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17:2863-9.
27. Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European organisation for research and treatment of cancer radiation oncology group. J Clin Oncol. 2007;25:4379-86. (Pubitemid 350013843)
28. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer. 1996;78:2313-7. (Pubitemid 26392829)
29. Vass DG, Ainsworth R, Anderson JH, Murray D, Foulis AK, et al. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol. 2004;57:769-72. (Pubitemid 38901497)
30. Uemura M, Ikeda M, Yamamoto H, Kitani K, Tokuoka M, et al. Clinicopathological assessment of locally recurrent rectal cancer and relation to local re-recurrence. Ann Surg Oncol. 2011;18:1015-22.